Tuesday, 08 October 2013 09:19

Vaccines in US clinical development 2013

October 8, 2013 I The association of America’s biopharmaceutical companies (the Pharmaceutical Research and Manufacturers of America: PhRMA) recently released the report „Medicines in Development for Vaccines„. The report states that US companies are developing 271 vaccines in clinical stages to prevent or treat a variety of diseases including allergy, neurological diseases, cancer, infectious diseases and some others. The vast majority of vaccines is being developed for infections diseases (51%) followed by cancer vaccines (37%). Among the infectious disease vaccines are e.g. HIV, influneza, hepatitis C virus vaccines, but also vaccines against meningitis, Dengue virus, malaria, cytomegalovirus, herpes simplex virus and many more. The report includes an introduction into and overview of the vaccines field. It can be downloaded at the PhRMA site at http://phrma.org/sites/default/files/pdf/Vaccines_2013.pdf

Published in Blog

La Merie Publishing 
· Badstrasse 11 · 97990 Weikersheim · Germany · T +49-711-1289 0987 ·
 F +49-3212-1267 572 · publishing@lamerie.com